Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Ainciburu M"'
Autor:
Serrano G; Computational Biology Program CIMA-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain.; Biological and Environmental Science and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia., Berastegui N; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Díaz-Mazkiaran A; Computational Biology Program CIMA-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain.; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., García-Olloqui P; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Rodriguez-Res C; Computational Biology Program CIMA-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain., Huerga-Dominguez S; Hematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain., Ainciburu M; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Vilas-Zornoza A; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Martin-Uriz PS; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Aguirre-Ruiz P; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Ullate-Agote A; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain., Ariceta B; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain., Lamo-Espinosa JM; Department of Orthopedics, Clínica Universidad de Navarra, Pamplona, Spain., Acha P; MDS Research Group, Josep Carreras Leukaemia Research Institut, Universitat Autònoma de Barcelona, Barcelona, Spain.; Service of Hematology, Hospital Universitari Vall d'Hebron, Barcelona; Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain., Calvete O; MDS Research Group, Josep Carreras Leukaemia Research Institut, Universitat Autònoma de Barcelona, Barcelona, Spain., Jimenez T; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain.; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain., Molero A; Service of Hematology, Hospital Universitari Vall d'Hebron, Barcelona; Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain., Montoro MJ; Service of Hematology, Hospital Universitari Vall d'Hebron, Barcelona; Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain., Díez-Campelo M; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain.; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain., Valcarcel D; Service of Hematology, Hospital Universitari Vall d'Hebron, Barcelona; Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain., Solé F; MDS Research Group, Josep Carreras Leukaemia Research Institut, Universitat Autònoma de Barcelona, Barcelona, Spain., Alfonso-Pierola A; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain.; Hematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain., Ochoa I; Instituto de Ciencia de los Datos e Inteligencia Artificial (DATAI), University of Navarra, Pamplona, Spain.; Department of Electrical and Electronics engineering, School of Engineering (Tecnun), University of Navarra, Donostia, Spain., Prósper F; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain. fprosper@unav.es.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain. fprosper@unav.es.; Hematology and Cell Therapy Service, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain. fprosper@unav.es., Ezponda T; Hematology-Oncology Program, CIMA, Cancer Center Clínica Universidad de Navarra (CCUN), IdiSNA, Pamplona, Spain. tezponda@unav.es.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain. tezponda@unav.es., Hernaez M; Computational Biology Program CIMA-Universidad de Navarra, Cancer Center Clínica Universidad de Navarra (CCUN), IdISNA, Pamplona, Spain. mhernaez@unav.es.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Madrid, Spain. mhernaez@unav.es.; Instituto de Ciencia de los Datos e Inteligencia Artificial (DATAI), University of Navarra, Pamplona, Spain. mhernaez@unav.es.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 20; Vol. 15 (1), pp. 5272. Date of Electronic Publication: 2024 Jun 20.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zufiaurre, N. Berastegui, Serrano, G., Mazkiaran, A. Díaz, Huerga, S., García-Olloqui, P., Ainciburu, M., Alfonso, A., Vilas-Zornoza, A., Martin, P. San, De Espinosa, J.M. Lamo, Acha, P., Solas, T. Jiménez, Molero, A., Montoro, M.J., Campelo, M., Valcárcel, D., Solé, F., Ochoa, I., Hernaez, M., Ezponda, T., Prosper, F.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Autor:
Diaz-Mazkiaran, A., De La Fuente, J., Serrano, G., Ainciburu, M., García-Olloqui, P., Berastegui, N., Alfonso, A., Vilas-Zornoza, A., San-Martin, P., Lamo-Espinosa, J.M., Julián, M. San, Acha, P., Solas, T. Jiménez, López-Cadenas, F., Molero, A., Montoro, M.J., Solé, F., Diez-Campelo, M., Valcárcel, D., Prosper, F., Hernaez, M., Ezponda, T.
Publikováno v:
In Leukemia Research May 2023 128 Supplement
Autor:
Ainciburu M; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Ezponda T; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Berastegui N; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain., Alfonso-Pierola A; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Clinica Universidad de Navarra, Pamplona, Spain., Vilas-Zornoza A; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., San Martin-Uriz P; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Alignani D; Flow Cytometry Core, Universidad de Navarra, Pamplona, Spain., Lamo-Espinosa J; Clinica Universidad de Navarra, Pamplona, Spain., San-Julian M; Clinica Universidad de Navarra, Pamplona, Spain., Jiménez-Solas T; Hospital Universitario de Salamanca, Salamanca, Spain., Lopez F; Hospital Universitario de Salamanca, Salamanca, Spain., Muntion S; Hospital Universitario de Salamanca, Salamanca, Spain.; Red de Investigación Cooperativa en Terapia Celular TerCel, ISCIII., Madrid, Spain., Sanchez-Guijo F; Hospital Universitario de Salamanca, Salamanca, Spain.; Red de Investigación Cooperativa en Terapia Celular TerCel, ISCIII., Madrid, Spain., Molero A; Department of Hematology, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Montoro J; Department of Hematology, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Serrano G; Computational Biology Program, Universidad de Navarra, Pamplona, Spain., Diaz-Mazkiaran A; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Computational Biology Program, Universidad de Navarra, Pamplona, Spain., Lasaga M; Translational Bioinformatics Unit, NavarraBiomed, Pamplona, Spain., Gomez-Cabrero D; Translational Bioinformatics Unit, NavarraBiomed, Pamplona, Spain.; Biological & Environmental Sciences & Engineering Division, King Abdullah University of Science and Technology, Thuwal, Saudi Arabia., Diez-Campelo M; Hospital Universitario de Salamanca, Salamanca, Spain., Valcarcel D; Department of Hematology, Vall d'Hebron Hospital Universitari, Barcelona, Spain., Hernaez M; Computational Biology Program, Universidad de Navarra, Pamplona, Spain., Romero JP; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain., Prosper F; Area de Hemato-Oncología, Centro de Investigación Médica Aplicada, Universidad de Navarra, Instituto de investigación sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Clinica Universidad de Navarra, Pamplona, Spain.; Red de Investigación Cooperativa en Terapia Celular TerCel, ISCIII., Madrid, Spain.
Publikováno v:
ELife [Elife] 2023 Jan 11; Vol. 12. Date of Electronic Publication: 2023 Jan 11.
Autor:
Berastegui N; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Ainciburu M; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Romero JP; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Garcia-Olloqui P; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Alfonso-Pierola A; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Hematology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008, Pamplona, Spain., Philippe C; Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, England, UK., Vilas-Zornoza A; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., San Martin-Uriz P; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain., Ruiz-Hernández R; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), San Sebastian, Spain., Abarrategi A; Center for Cooperative Research in Biomaterials (CIC biomaGUNE), Basque Research and Technology Alliance (BRTA), San Sebastian, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Ordoñez R; Institute for Systems Genetics, NYU School of Medicine, New York, NY, USA., Alignani D; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Sarvide S; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Castro-Labrador L; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Lamo-Espinosa JM; Department of Orthopedic Surgery and Traumatology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008, Pamplona, Spain., San-Julian M; Department of Orthopedic Surgery and Traumatology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008, Pamplona, Spain., Jimenez T; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain., López-Cadenas F; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain., Muntion S; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain., Sanchez-Guijo F; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain., Molero A; Department of Hematology, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Montoro MJ; Department of Hematology, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Tazón B; Department of Hematology, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Serrano G; Computational Biology Program, Institute for data science and artificial intelligence (datai), CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain., Diaz-Mazkiaran A; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain.; Computational Biology Program, Institute for data science and artificial intelligence (datai), CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain., Hernaez M; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Computational Biology Program, Institute for data science and artificial intelligence (datai), CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Navarra, Spain., Huerga S; Department of Hematology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008, Pamplona, Spain., Bewicke-Copley F; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Rio-Machin A; Centre for Genomics and Computational Biology, Barts Cancer Institute, Queen Mary University of London, London, UK., Maurano MT; Institute for Systems Genetics, NYU School of Medicine, New York, NY, USA.; Department of Pathology, NYU School of Medicine, New York, NY, USA., Díez-Campelo M; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Hematology, Hospital Universitario de Salamanca-IBSAL, Universidad de Salamanca, Salamanca, Spain., Valcarcel D; Department of Hematology, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Rouault-Pierre K; Department of Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, England, UK., Lara-Astiaso D; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain., Ezponda T; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain. tezponda@unav.es.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. tezponda@unav.es., Prosper F; Department of Hematology-Oncology, CIMA Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain. fprosper@unav.es.; Centro de Investigación Biomédica en Red de Cáncer, CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. fprosper@unav.es.; Department of Hematology, Clínica Universidad de Navarra, Universidad de Navarra and CCUN, 31008, Pamplona, Spain. fprosper@unav.es.
Publikováno v:
Nature communications [Nat Commun] 2022 Dec 09; Vol. 13 (1), pp. 7619. Date of Electronic Publication: 2022 Dec 09.
Autor:
Ainciburu M; Program of Hemato-Oncology, University of Navarra, Pamplona 31008, Spain.; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Morgan DM; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., DePasquale EAK; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Love JC; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Prósper F; Program of Hemato-Oncology, University of Navarra, Pamplona 31008, Spain., van Galen P; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA.; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, USA.
Publikováno v:
Bioinformatics (Oxford, England) [Bioinformatics] 2022 Jul 11; Vol. 38 (14), pp. 3645-3647.
Autor:
DePasquale EAK; Division of Hematology, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States.; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, United States., Ssozi D; Division of Hematology, Brigham and Women's Hospital, Boston, MA, United States.; Broad Institute of MIT and Harvard, Cambridge, MA, United States., Ainciburu M; Hemato-Oncology Program, Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Instituto de Investigación Sanitaria de Navarra (IDISNA), Pamplona, Spain., Good J; Division of Hematology, Brigham and Women's Hospital, Boston, MA, United States.; Department of Human Biology, Sattler College, Boston, MA, United States., Noel J; Division of Hematology, Brigham and Women's Hospital, Boston, MA, United States.; Broad Institute of MIT and Harvard, Cambridge, MA, United States., Villanueva MA; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.; Division of Health Science & Technology, Harvard Medical School, Cambridge, MA, United States.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, United States.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, and Massachusetts General Hospital, Cambridge, MA, United States., Couturier CP; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.; Division of Health Science & Technology, Harvard Medical School, Cambridge, MA, United States., Shalek AK; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States.; Division of Health Science & Technology, Harvard Medical School, Cambridge, MA, United States.; Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, MA, United States.; Ragon Institute, Harvard University, Massachusetts Institute of Technology, and Massachusetts General Hospital, Cambridge, MA, United States.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, United States., Aranki SF; Division of Thoracic and Cardiac Surgery, Brigham and Women's Hospital, Boston, MA, United States., Mallidi HR; Division of Thoracic and Cardiac Surgery, Brigham and Women's Hospital, Boston, MA, United States., Griffin GK; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, United States., Lane AA; Department of Medicine, Harvard Medical School, Boston, MA, United States.; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., van Galen P; Division of Hematology, Brigham and Women's Hospital, Boston, MA, United States.; Department of Medicine, Harvard Medical School, Boston, MA, United States.; Broad Institute of MIT and Harvard, Cambridge, MA, United States.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Mar 10; Vol. 13, pp. 809414. Date of Electronic Publication: 2022 Mar 10 (Print Publication: 2022).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xinyi, Yang1 (AUTHOR), Vladimirovich, Reshetov Igor1 (AUTHOR), Beeraka, Narasimha M.2,3,4,5 (AUTHOR) bnmurthy24@gmail.com, Satyavathi, Allaka6 (AUTHOR), Kamble, Dinisha4 (AUTHOR), Nikolenko, Vladimir N.2 (AUTHOR), Lakshmi, Allaka Naga7 (AUTHOR), Basappa, Basappa8 (AUTHOR), Reddy Y, Padmanabha3 (AUTHOR), Fan, Ruitai9 (AUTHOR) fccfanrt@zzu.edu.cn, Liu, Junqi9 (AUTHOR)
Publikováno v:
Stem Cell Research & Therapy. 11/6/2024, Vol. 15 Issue 1, p1-29. 29p.